SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
24h
Actuel
Min
111.55
Max
112.05
Revenu | 250M 902M |
|---|---|
Ventes | 63M 5.3B |
Rendement du dividende | 1.34 |
Marge bénéficiaire | 16.961 |
Recommandations | Achat |
|---|---|
Prévisions sur 12 Mois | +23.16% upside |
Rendement du dividende Moyenne du Secteur | 1.34% 2.24% |
|---|---|
Prochains Résultats | 13 mai 2026 |
Capitalisation Boursière | 98B |
|---|---|
Ouverture précédente | 111.65 |
Clôture précédente | 111.65 |
By Trading Central
Confiance
Strong Bearish Evidence
121.15 / 123.55 Support & Résistance
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
5 mars 2026, 06:28 UTC
Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings
DJ
Lire
13 nov. 2025, 13:40 UTC
Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update
DJ
Lire
13 nov. 2025, 06:24 UTC
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
DJ
Lire
1 avr. 2026, 12:06 UTC
Merck KGaA Completes Acquisition of JSR Life Sciences' Chromatography Business
DJ
Lire
5 mars 2026, 08:40 UTC
Germany's Merck KGaA Issues Weaker-Than-Expected Guidance -- Market Talk
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA Sees 2026 Ebitda Before Special Items at EUR5.5B-EUR6B
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA Sees 2026 Adj EPS EUR7.10-Adj EPS EUR8
DJ
Lire
5 mars 2026, 06:00 UTC
Analysts Saw Merck KGaA 2025 Ebitda Before Special Items EUR6.1B
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA Sees 2026 Sales EUR20B-EUR21B
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA Sees 2026 Organic Net Sales Ranging From 1% Fall to 2% Rise
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA 2025 Adj EPS EUR8.34
DJ
Lire
5 mars 2026, 06:00 UTC
Analysts Saw Merck KGaA 2025 Net Sales at EUR21.14B
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA Expects Considerable Foreign-Exchange Headwinds in 2026
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA Keeps Dividend at EUR2.20 a Share
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA 2025 After-Tax Profit EUR2.615B
DJ
Lire
5 mars 2026, 06:00 UTC
Germany's Merck KGaA Says Organic Net Sales Grew 3.1% in 2025
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA 2025 Sales EUR21.1B
DJ
Lire
5 mars 2026, 06:00 UTC
Merck KGaA 2025 Ebitda Before Special Items EUR6.11B
DJ
Lire
12 févr. 2026, 15:20 UTC
Sanofi Shares Fall After CEO Change -- Update
DJ
Lire
20 janv. 2026, 09:54 UTC
DAVOS: Merck KGaA Not in a Hurry for M&A, CEO Says -- Market Talk
DJ
Lire
13 nov. 2025, 07:57 UTC
Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Says Guidance Midpoint Remains Unchanged
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Sales Growth of Around 3%
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA 3Q After-Tax Profit EUR898M
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors
DJ
Lire
Variation de prix
By TipRanks
Prévisions sur 12 Mois
Moyen 138 EUR 23.16%
Haut 152 EUR
Bas 112 EUR
Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
By TipRanks
Achat
8 ratings
5
Achat
3
Maintien
0
Vente
Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.
By Trading Central
Court Terme
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Moyen Terme
Neutral Evidence
The bullish and bearish events are balanced.
Long Terme
Bearish Evidence
All events are bearish.
Frais Généraux et Administratifs
Dépenses d'exploitation
Résultat avant impôt
Ventes
Coût des ventes
Marge brute des ventes
Charges d'intérêt sur la dette
EBITDA
Bénéfice d'exploitation
$